Data as of Jul 25
| +0.67 / +1.81%|
The 9 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 87.00, with a high estimate of 122.00 and a low estimate of 50.00. The median estimate represents a +130.89% increase from the last price of 37.68.
The current consensus among 9 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.